Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.73
-0.64 (-6.83%)
At close: Nov 20, 2024, 4:00 PM
8.90
+0.17 (1.95%)
After-hours: Nov 20, 2024, 7:14 PM EST
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PHAT stock have an average target of 22.5, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 157.73% from the current stock price of 8.73.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 13, 2024.
Analyst Ratings
The average analyst rating for PHAT stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +197.82% | Sep 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +197.82% | Sep 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +197.82% | Aug 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +197.82% | Aug 23, 2024 |
| Needham | Needham | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +197.82% | Aug 19, 2024 |
Financial Forecast
Revenue This Year
46.48M
from 682.00K
Increased by 6,714.96%
Revenue Next Year
182.98M
from 46.48M
Increased by 293.69%
EPS This Year
-5.99
from -3.93
EPS Next Year
-4.14
from -5.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 53.0M | 264.3M | 527.5M | ||
| Avg | 46.5M | 183.0M | 395.7M | ||
| Low | 38.2M | 133.4M | 268.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7,672.1% | 468.6% | 188.3% | ||
| Avg | 6,715.0% | 293.7% | 116.3% | ||
| Low | 5,494.3% | 187.0% | 46.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.72 | -3.08 | -0.35 | ||
| Avg | -5.99 | -4.14 | -1.93 | ||
| Low | -6.00 | -5.58 | -2.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.